Filing Details
- Accession Number:
- 0001209191-18-036186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-06 20:11:54
- Reporting Period:
- 2018-06-04
- Accepted Time:
- 2018-06-06 20:11:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1396814 | Pacira Pharmaceuticals Inc. | PCRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296965 | Marie Kristen Williams | C/O Pacira Pharmaceuticals, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054 | Cao And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-06-04 | 2,040 | $33.02 | 19,272 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.